References
- 1. Sabattini E, Bacci F, Sagramoso C, Pileri S: WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 2010, 102(3):83-87.
- 2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71(3):209-249.10.3322/caac.2166033538338
- 3. Zandvliet M: Canine lymphoma: a review. Vet Q 2016, 36(2):76-104.10.1080/01652176.2016.115263326953614
- 4. Economu L, Stell A, O’Neill D, Schofield I, Stevens K, Brodbelt D: Incidence and risk factors for feline lymphoma in UK primary-care practice. J Small Anim Pract 2021, 62(2):97-106.10.1111/jsap.13266798608733325082
- 5. Ward JM: Lymphomas and leukemias in mice. Exp Toxicol Pathol 2006, 57(5-6):377-381.10.1016/j.etp.2006.01.00716713211
- 6. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, Stagnaro E, Willett EV, Franceschi S, La Vecchia C, Hughes AM, Cozen W, Davis S, Severson RK, Bernstein L, Mayne ST, Dee FR, Cerhan JR, Zheng T: Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005, 14(4):925-933.10.1158/1055-9965.EPI-04-0693
- 7. Roman E, Smith AG: Epidemiology of lymphomas. Histopathology 2011, 58(1):4-14.10.1111/j.1365-2559.2010.03696.x
- 8. Magrath I: Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 2012, 156(6):744-756.10.1111/j.1365-2141.2011.09013.x
- 9. Huh J: Epidemiologic overview of malignant lymphoma. Korean J Hematol 2012, 47(2):92-104.10.5045/kjh.2012.47.2.92
- 10. Scott SH, Bahnson BJ: Senescence marker protein 30: functional and structural insights to its unknown physiological function. Biomol Concepts 2011, 2(6): 469-480.10.1515/BMC.2011.041
- 11. Henriques SF, Duque P, López-Fernández H, Vázquez N, Fdez-Riverola F, Reboiro-Jato M, Vieira CP, Vieira J: Multiple independent L-gulonolactone oxidase (GULO) gene losses and vitamin C synthesis reacquisition events in non-Deuterostomian animal species. BMC Evol Biol. 2019, 19(1):1-12.10.1186/s12862-019-1454-8
- 12. Sugimoto K, Yokokawa T, Misaka T, Nakazato K, Ishida T, Takeishi Y: Senescence marker protein 30 deficiency exacerbates pulmonary hypertension in hypoxia-exposed mice. Int Heart J 2019, 60(6):1430-1434.10.1536/ihj.19-19031735783
- 13. Yamaguchi M: Role of regucalcin in maintaining cell homeostasis and function. Int J Mol Med 2005, 15(3):371-389.10.3892/ijmm.15.3.371
- 14. Choi DW: Excitotoxic cell death. J Neurobiol 1992, 23(9):1261-1276.10.1002/neu.4802309151361523
- 15. Bo T, Yamamori T, Yamamoto K, Fujimoto M, Yasui H, Inanami O: Mitochondrial fission promotes radiation-induced increase in intracellular Ca2+ level leading to mitotic catastrophe in mouse breast cancer EMT6 cells. Biochem Biophys Res Commun 2020, 522(1):144-150.10.1016/j.bbrc.2019.11.02731757415
- 16. Mo Z, Zheng S, Lv Z, Zhuang Y, Lan X, Wang F, Lu X, Zhao Y, Zhou S: Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma. Sci Rep 2016, 6(1):1-10.10.1038/srep39376
- 17. Ipek V, Cangul IT, Akkoc A: Comparative evaluation of the cytological, histopathological and immunohistochemical findings of canine cutaneous and subcutaneous masses. Acta Vet-Beograd 2021, 71(1):61-84.10.2478/acve-2021-0005
- 18. Yancik R, Ries LA, editors. Cancer in older persons: an international issue in an aging world. Seminars in oncology; 2004: Elsevier.10.1053/j.seminoncol.2003.12.024
- 19. He W, Goodkind D, Kowal PR: An aging world: 2015. United States Census Bureau Washington, DC; 2016.
- 20. Maruyama N, Ishigami A, Kuramoto M, Handa S, Kubo S, Imasawa T, Seyama K, Shimosawa T, Kasahara Y: Senescence marker protein-30 knockout mouse as an aging model. Ann N Y Acad Sci 2004, 1019:383-387.10.1196/annals.1297.068
- 21. Jung KJ, Lee EK, Kim SJ, Song CW, Maruyama N, Ishigami A, Kim ND, Im DS, Yu BP, Chung HY: Anti-inflammatory activity of SMP30 modulates NF-κB through protein tyrosine kinase/phosphatase balance. J Mol Med (Berl) 2015, 93(3):343-356.10.1007/s00109-014-1219-125394676
- 22. Greten FR, Grivennikov SI: Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 2019, 51(1):27-41.10.1016/j.immuni.2019.06.025683109631315034
- 23. Fujita T, Inoue H, Kitamura T, Sato N, Shimosawa T, Maruyama N: Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca2+-pumping activity in Hep G2 cells. Biochem Biophys Res Commun 1998, 250(2):374-380.10.1006/bbrc.1998.93279753637
- 24. Choi DW: Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 1995, 18(2):58-60.10.1016/0166-2236(95)80018-W
- 25. Zhang W-M, Zhou J, Ye QJ: Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+. Life Sci 2008, 82(13-14):764-771.10.1016/j.lfs.2008.01.00818294657
- 26. Wo lfesberger B, Fuchs-Baumgartinger A, Greß V, Hammer SE, Gradner G, Knödl K, Tichy A, Rütgen BC, Beham-Schmid C: World Health Organisation classification of lymphoid tumours in veterinary and human medicine: a comparative evaluation of gastrointestinal lymphomas in 61 cats. J Comp Pathol 2018, 159:1-10.10.1016/j.jcpa.2017.12.00629598998